ESSA Pharma Inc. (EPIX)
EPIX Stock Price Chart
Explore ESSA Pharma Inc. interactive price chart. Choose custom timeframes to analyze EPIX price movements and trends.
EPIX Company Profile
Discover essential business fundamentals and corporate details for ESSA Pharma Inc. (EPIX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
13 Mar 2015
Employees
35.00
Website
https://www.essapharma.comCEO
David Ross Parkinson
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
EPIX Financial Timeline
Browse a chronological timeline of ESSA Pharma Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 16 Dec 2025
Earnings released on 13 Aug 2025
EPS came in at -$0.09 surpassing the estimated -$0.17 by +47.06%.
Dividend declared on 5 Aug 2025
A dividend of $1.69 per share was announced, adjusted to $1.69.
Earnings released on 8 May 2025
EPS came in at -$0.14 surpassing the estimated -$0.19 by +26.32%.
Earnings released on 11 Feb 2025
EPS came in at -$0.19 falling short of the estimated -$0.18 by -5.56%.
Earnings released on 17 Dec 2024
EPS came in at -$0.14 surpassing the estimated -$0.19 by +26.32%.
Earnings released on 5 Aug 2024
EPS came in at -$0.16 surpassing the estimated -$0.26 by +38.46%.
Earnings released on 14 May 2024
EPS came in at -$0.20 falling short of the estimated -$0.19 by -5.26%.
Earnings released on 13 Feb 2024
EPS came in at -$0.14 surpassing the estimated -$0.17 by +17.65%.
Earnings released on 12 Dec 2023
EPS came in at -$0.12 surpassing the estimated -$0.22 by +45.45%.
Earnings released on 8 Aug 2023
EPS came in at -$0.17 surpassing the estimated -$0.20 by +15.00%.
Earnings released on 9 May 2023
EPS came in at -$0.16 surpassing the estimated -$0.20 by +20.00%.
Earnings released on 7 Feb 2023
EPS came in at -$0.15 surpassing the estimated -$0.24 by +37.50%.
Earnings released on 13 Dec 2022
EPS came in at -$0.14 surpassing the estimated -$0.28 by +50.00%.
Earnings released on 4 Aug 2022
EPS came in at -$0.20 surpassing the estimated -$0.27 by +25.93%.
Earnings released on 10 May 2022
EPS came in at -$0.25 matching the estimated -$0.25.
Earnings released on 3 Feb 2022
EPS came in at -$0.21 surpassing the estimated -$0.23 by +8.70%.
Earnings released on 18 Nov 2021
EPS came in at -$0.20 surpassing the estimated -$0.23 by +13.04%.
Earnings released on 16 Aug 2021
EPS came in at -$0.21 surpassing the estimated -$0.26 by +19.23%.
Earnings released on 6 May 2021
EPS came in at -$0.36 falling short of the estimated -$0.21 by -71.43%.
Earnings released on 11 Feb 2021
EPS came in at -$0.20 falling short of the estimated -$0.17 by -17.65%.
Earnings released on 15 Dec 2020
EPS came in at -$0.17 surpassing the estimated -$0.20 by +15.00%.
EPIX Stock Performance
Access detailed EPIX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.